Abiopharma

Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA

Autohome Inc. Announces Results of 2025 Annual General Meeting

Change - Announcement of Appointment: Appointment of Independent Non-Executive Director - Mr Lim Teck Chai, Danny

Register of shareholders, changes and share capital status – exercise of warrants granted to employees

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Director

General Announcement: USE OF RIGHTS ISSUE PROCEEDS

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Financial Statements and Related Announcement: Notification of Results Release

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt

Change in holdings of a senior officer in a securities bank of a subsidiary company